Centennial Bank’s Biogen BIIB Stock Holding History

Centennial Bank’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Hold	800	–	–	0.05%	157
2025 Q4	$141K	Hold	800	–	–	0.06%	158
2025 Q3	$112K	Hold	800	–	–	0.04%	169
2025 Q2	$100K	Hold	800	–	–	0.04%	175
2025 Q1	$109K	Hold	800	–	–	0.05%	164
2024 Q4	$122K	Hold	800	–	–	0.06%	151
2024 Q3	$155K	Hold	800	–	–	0.07%	141
2024 Q2	$185K	Hold	800	–	–	0.09%	128
2024 Q1	$173K	Hold	800	–	–	0.09%	129
2023 Q4	$207K	Hold	800	–	–	0.12%	122
2023 Q3	$206K	Sell	800 -350	-30%	-$93.6K	0.14%	119
2023 Q2	$328K	Hold	1,150	–	–	0.22%	92
2023 Q1	$320K	Hold	1,150	–	–	0.21%	104
2022 Q4	$318K	Buy	+1,150	New	+$325K	0.18%	112

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Centennial Bank's BIIB Position: Q1 2026 in Review

Centennial Bank held its Biogen (BIIB) position steady in Q1 2026 at 800 shares worth $147K. The position accounts for 0.05% of the portfolio, ranked #157.

Centennial Bank first reported a position in BIIB in Q4 2022 and has held it in 14 quarters since. The position peaked at $328K in Q2 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Centennial Bank held 800 shares of Biogen worth $147K as of Q1 2026.
Centennial Bank left its Biogen share count unchanged in Q1 2026.
Biogen made up 0.05% of Centennial Bank's portfolio in Q1 2026, its #157 holding.
Centennial Bank first reported a position in Biogen in Q4 2022 and has held it in 14 quarters since.
Centennial Bank's Biogen position peaked at $328K in Q2 2023.
1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Centennial Bank's 13F filing for Q1 2026, filed 6 May 2026.